SI-Bone Inc (NASDAQ:SIBN) CEO Jeffrey W. Dunn sold 40,000 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $18.51, for a total value of $740,400.00.
Shares of NASDAQ:SIBN traded up $0.07 during midday trading on Friday, reaching $18.51. 281,300 shares of the company’s stock traded hands, compared to its average volume of 121,081. The company has a fifty day simple moving average of $17.32 and a two-hundred day simple moving average of $17.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 11.55 and a current ratio of 12.00. The company has a market cap of $477.76 million and a P/E ratio of -26.07. SI-Bone Inc has a 1 year low of $14.08 and a 1 year high of $23.03.
Separately, ValuEngine lowered SI-Bone from a “buy” rating to a “hold” rating in a research report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $24.75.
SI-Bone Company Profile
SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Recommended Story: Commodities
Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.